Immunocompromised adults or those who are older than 65 should get a second dose of the latest COVID-19 vaccine, the Centers ...

The novel coronavirus SARS-CoV-2 has an enzyme that can counteract a cell's innate defense mechanism against viruses, ...

Franciscan Health infectious disease physician Dr. Erica Kaufman West said she is not at all surprised that COVID variants ...

The CDC recommends that immunocompromised people age 65 and older should get a second dose of the 2024-2025 COVID vaccine.

The Centers for Disease Control and Prevention’s vaccine advisory group, the Advisory Committee for Immunization Practices ...

Researchers found that vaccination rates decreased as the social vulnerability index quartile increased, especially among ...

Researchers at the Icahn School of Medicine have unveiled the AMETA Nanobody Platform, which effectively combats SARS-CoV-2 ...

Scientists at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues in the field, have developed an ...

Researchers are preparing for additional preclinical and potential clinical trials to evaluate AMETA’s therapeutic potential across various diseases.

Scientists have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade ...

Scientists at the Icahn School of Medicine at Mount Sinai, in collaboration with colleagues in the field, have developed an ...